PLYMOUTH MEETING, PA – Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), a pharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases, has announced its participation in the upcoming 2025 Cantor Global Healthcare Conference. The company’s management team is scheduled to engage in a fireside chat during the prestigious industry event.

The conference, a key gathering for healthcare leaders, investors, and analysts, provides a platform for companies to share insights into their strategies, pipelines, and market outlook. Harmony Biosciences' participation underscores its commitment to transparency and engagement with the investment community. The fireside chat format allows for a more in-depth and conversational discussion, providing attendees with a valuable opportunity to learn more about the company's vision and progress.

While specific details regarding the topics to be covered during the fireside chat have not yet been released, it is anticipated that the management team will discuss Harmony Biosciences' current commercial performance, ongoing research and development efforts, and future growth plans. The presentation will likely highlight the company's lead product, Wakix (pitolisant), and its role in treating excessive daytime sleepiness in adult patients with narcolepsy.

Investors and industry observers will be keen to hear updates on any potential expansion of Wakix's indications, as well as progress on Harmony Biosciences' other pipeline programs targeting unmet needs in the rare neurological disease space. The conference provides a valuable opportunity for the company to articulate its strategic priorities and reinforce its position as a key player in the biopharmaceutical sector.

The Cantor Global Healthcare Conference is renowned for attracting a diverse audience of healthcare professionals and investors. Harmony Biosciences' presence at the event demonstrates its proactive approach to investor relations and its commitment to keeping stakeholders informed about its ongoing progress and future direction. Further details regarding the date and time of the fireside chat are expected to be released closer to the conference date.